Results
|
421.
|
|
|
422.
|
|
|
423.
|
|
|
424.
|
|
|
425.
|
|
|
426.
|
|
|
427.
|
|
|
428.
|
|
|
429.
|
|
|
430.
|
|
|
431.
|
|
|
432.
|
Serum IL-17F does not predict poor response to IM IFNβ-1a in relapsing-remitting MS. [electronic resource] by
- Bushnell, S E
- Zhao, Z
- Stebbins, C C
- Cadavid, D
- Buko, A M
- Whalley, E T
- Davis, J A
- Versage, E M
- Richert, J R
- Axtell, R C
- Steinman, L
- Medori, R
Producer: 20121015
In:
Neurology vol. 79
Availability: No items available.
|
|
433.
|
|
|
434.
|
|
|
435.
|
Immune thrombocytopenia in alemtuzumab-treated MS patients: Incidence, detection, and management. [electronic resource] by
- Cuker, Adam
- Bass, Ann D
- Nadj, Congor
- Agius, Mark A
- Steingo, Brian
- Selmaj, Krzysztof W
- Thoits, Timothy
- Guerreiro, Alexandre
- Van Wijmeersch, Bart
- Ziemssen, Tjalf
- Meuth, Sven G
- LaGanke, Christopher C
- Thangavelu, Karthinathan
- Rodriguez, Claudio E
- Baker, Darren P
- Margolin, David H
- Jannsens, Ann
Producer: 20201116
In:
Multiple sclerosis (Houndmills, Basingstoke, England) vol. 26
Availability: No items available.
|
|
436.
|
Infection risk with alemtuzumab decreases over time: pooled analysis of 6-year data from the CAMMS223, CARE-MS I, and CARE-MS II studies and the CAMMS03409 extension study. [electronic resource] by
- Wray, Sibyl
- Havrdova, Eva
- Snydman, David R
- Arnold, Douglas L
- Cohen, Jeffrey A
- Coles, Alasdair J
- Hartung, Hans-Peter
- Selmaj, Krzysztof W
- Weiner, Howard L
- Daizadeh, Nadia
- Margolin, David H
- Chirieac, Madalina C
- Compston, D Alastair S
Producer: 20200708
In:
Multiple sclerosis (Houndmills, Basingstoke, England) vol. 25
Availability: No items available.
|
|
437.
|
|
|
438.
|
|
|
439.
|
|
|
440.
|
|